Inventor · disambiguated record
Jiping Zha
Also filed as: ZHA JIPING
7 granted patents·6 pending applications·28 citations·filing 2007–2023
82Inventor score
Files withAPOLLOMICS INC3CB THERAPEUTICS INC3GENENTECH INC2ADAGENE PTE LTD1CROWN BIOSCIENCE INC TAICANG1
Top patents by PatentIndex Score
13 records- 0187US10543284B2Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Jan 28, 2020·6 cites·36 claims
- 0287US10435470B2Anti-PD-L1 antibodiesCB THERAPEUTICS INC·Filed 2015·Granted Oct 8, 2019·9 cites·30 claims
- 0387US10428146B2Anti PD-1 antibodiesCB THERAPEUTICS INC·Filed 2015·Granted Oct 1, 2019·9 cites·26 claims
- 0483US11560429B2Anti PD-1 antibodiesAPOLLOMICS INC·Filed 2021·Granted Jan 24, 2023·1 cites·13 claims
- 0582US11111300B2Anti PD-L1 antibodiesCB THERAPEUTICS INC·Filed 2019·Granted Sep 7, 2021·2 cites·31 claims
- 0677US10981994B2Anti PD-1 antibodiesAPOLLOMICS INC·Filed 2019·Granted Apr 20, 2021·1 cites·24 claims
- 0769US11827707B2Anti PD-L1 antibodiesAPOLLOMICS INC·Filed 2021·Granted Nov 28, 2023·0 cites·25 claims
- 0860US2023107304A1Methods of treating cancer and tumor-related weight loss and cachexiaNGM BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0959US2025326847A1Activatable anti-ctla4 antibodies for treating cancerADAGENE PTE LTD·Filed 2023·Application pending·0 cites
- 1048US2014037625A1Biomarkers and methods of treatmentGENENTECH INC·Filed 2013·Application pending·0 cites
- 1147US2009068110A1Antibodies to insulin-like growth factor receptorGENENTECH INC·Filed 2007·Application pending·0 cites
- 1242US2015282460A1Animal model with human immune systemCROWN BIOSCIENCE INC TAICANG·Filed 2015·Application pending·0 cites
- 1341US2012089541A1Biomarkers and methods of treatmentPATEL PREMAL H·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jiping Zha files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →